(Q24658545)

1

0 references

Srinivas Sadda

2

0 references

Xiao-Yan Li

3

0 references

Harry Cui

4

0 references

Yehia Hashad

5

0 references

language of work or name

English

0 references

publication date

June 2016

0 references

number of pages

6

1 reference

British Journal of Ophthalmology

inferred from page(s)

published in

0 references

volume

100

0 references

issue

6

0 references

page(s)

796-801

0 references

cites work

New approaches for the treatment of diabetic macular oedema: recommendations by an expert panel

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893085

Current concepts in diabetic retinopathy

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893085

Anti-vascular endothelial growth factor therapy for diabetic macular edema

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893085

Preliminary results of an intravitreal dexamethasone implant (Ozurdex®) in patients with persistent diabetic macular edema

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893085

Dexamethasone intravitreal implant in combination with laser photocoagulation for the treatment of diffuse diabetic macular edema

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893085

Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893085

Inflammation in diabetic retinopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893085

Diabetic macular oedema: physical, physiological and molecular factors contribute to this pathological process

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893085

Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893085

Diabetic macular edema: pathogenesis and treatment

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893085

Comparison of macular thickness measurements between time domain and spectral domain optical coherence tomography

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893085

Discrepancy between fluorescein angiography and optical coherence tomography in detection of macular disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893085

Immunological mechanisms in the pathogenesis of diabetic retinopathy

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893085

Temporal variation in diabetic macular edema measured by optical coherence tomography

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4893085

Triamcinolone acetonide protects the rat retina from STZ-induced acute inflammation and early vascular leakage.

28 September 2017

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2015-306823

Intravitreal injection of corticosteroid attenuates leukostasis and vascular leakage in experimental diabetic retina

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2015-306823

Three-year, randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with diabetic macular edema.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2015-306823

Dexamethasone intravitreal implant for treatment of diabetic macular edema in vitrectomized patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2015-306823

UKPDS 50: risk factors for incidence and progression of retinopathy in Type II diabetes over 6 years from diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1136%2FBJOPHTHALMOL-2015-306823

Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26581718

12 December 2020

inferred from PubMed ID database lookup

Classification of diabetic retinopathy from fluorescein angiograms. ETDRS report number 11. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26581718

12 December 2020

inferred from PubMed ID database lookup

Correlation between optical coherence tomography and fluorescein angiography findings in diabetic macular edema

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/26581718

12 December 2020